Riverpark Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Riverpark Capital Management's LLY Position: Q4 2025 in Review
Riverpark Capital Management reduced its Eli Lilly (LLY) stake by 25% in Q4 2025, selling an estimated $737K and leaving 2,325 shares worth $2.5M. The position accounts for 4.83% of the portfolio, ranked #5.
Riverpark Capital Management first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.62M in Q2 2025. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Riverpark Capital Management held 2,325 shares of Eli Lilly worth $2.5M as of Q4 2025.
- Riverpark Capital Management sold 771 Eli Lilly shares in Q4 2025, an estimated $737K.
- Eli Lilly made up 4.83% of Riverpark Capital Management's portfolio in Q4 2025, its #5 holding.
- Riverpark Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
- Riverpark Capital Management's Eli Lilly position peaked at $2.62M in Q2 2025.
- 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Riverpark Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.